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Objectives
This document describes a framework for creating linkages between community pharmacists 
and physicians that benefit community collaborators and the patients they serve. 
The objectives of this document are to:
 
 
 
 
y Discuss the importance of community-clinical linkages specific to community pharmacists 
and physicians. 
y Illustrate examples of existing community-clinical linkages between community pharmacists 
and physicians.
y Discuss common barriers to and potential solutions for creating community-clinical linkages 
between community pharmacists and physicians.
y Provide a framework for how community pharmacists and physicians might approach the 
development of a link to help community members. 
This resource serves as a supplement to Community-Clinical Linkages for the Prevention and 
Control of Chronic Diseases: A Practitioner’s Guide,1 and it specifically focuses on creating 
community-clinical linkages between community pharmacists and physicians using the 
LINKAGE framework.
Background
Community-clinical linkages are connections between the community, clinics, and other 
settings where primary care is provided to improve population health.1 Community-clinical 
linkages help to ensure that those at high risk for chronic diseases and their complications have 
access to quality community resources to best manage their conditions.2 Community-clinical 
linkages may aid in facilitating access, referral, and payment for effective community programs.1 
In this supplement, the community-clinical linkage described is between community 
pharmacists and physicians. These linkages are dependent on collaborative care relationships 
between community pharmacists and physicians, and they are intended to connect the two 
groups. Community pharmacists are defined as pharmacists in community settings (e.g., 
independent, chain, supermarket, mass merchandiser community pharmacies), and physicians 
are clinicians in health care settings (e.g., hospitals, primary care clinics). 
Pharmacists’ education and training fully prepares them for participation in and contribution 
to team-based care, disease management, and the provision of wellness services. However, 
pharmacists’ skills may be underused, as patients and physicians are not always aware of 
the extent of pharmacists’ training and qualifications. Pharmacists in the community serve a 
valuable role, as they are often the most accessible health care to patients; 86% of Americans 
live within 5 miles of a community pharmacy.3 Pharmacists are able to provide medication 
assessment and counseling and lifestyle management recommendations. They can serve as 
key partners in improving outcomes associated with chronic diseases, such as cardiovascular 
disease and diabetes. To increase patient access to quality care, physicians and pharmacists can 
partner to create community-clinical linkages. 
Community pharmacists provide many clinical services that include triaging patients, referring 
patients to physicians, and working with physicians to manage patients’ chronic conditions. The 
collaboration between community pharmacists and physicians can lead to improved medical 
care and help improve access and efficiency of health care in the community.2 The types of 
activities that can occur as part of these linkages can include:
 y Health assessment in the pharmacy and subsequent referral to physician for diagnosis  
or treatment.
 y Physician referral of patients to the pharmacist for assistance with medications or chronic 
condition management. 
 y Pharmacist triage of patient into primary care after identifying medication-related problems 
or other health conditions that arise or worsen.
Successful Models of Pharmacist-Physician 
Collaborations
Collaborative care is the provision of health care by at least two practitioners working together 
with the patient to accomplish shared goals. Collaborative care has been shown to improve 
hypertension control and cholesterol management, especially when the team involves a 
physician or nurse and a pharmacist.4 Two examples of collaborative care models involving 
pharmacists and physicians include Medication Therapy Management (MTM) and Collaborative 
Drug Therapy Management (CDTM).
MTM is a service provided by pharmacists (in collaboration with a physician or other prescriber) 
to help patients get the best benefits from their medications.2 MTM services are patient 
centered and empower patients to actively work on managing their medications and reach 
their therapeutic goals, such as blood pressure control, lipid reduction, and diabetes control.5
CDTM is a formal collaborative practice model between physicians and pharmacists where 
pharmacists—per a collaborative practice agreement—assume the responsibility for 
monitoring and managing drug therapy to optimize patient outcomes and safety. By engaging 
pharmacists as members of the health care team, providers can better identify and control high 
blood pressure, improve cholesterol management, and reduce health care costs. 
One successful example of a pharmacist-directed MTM program that demonstrated significant 
improvements in hypertension control is the Asheville Project. The Asheville Project was 
initiated in 1997 to provide intensive education about correct medication usage and lifestyle 
approaches coordinated between physicians, pharmacists, and other health care practitioners. 
The project originally focused on diabetes, but it was later expanded to include hypertension 
and asthma.6,7 In one evaluation of the study, participants’ mean systolic blood pressure was 
reduced from 137.3 mmHg to 126.3 mmHg, and participants’ mean diastolic blood pressure was 
reduced from 82.6 mmHg to 77.8 mmHg. The Asheville model reduced the health care costs 
associated with a cardiovascular event from $14,343 to $9,931.8 
Project IMPACT has also demonstrated that pharmacists can be integrated into a variety of 
practice settings and be involved in collaborative care of patients. Care was delivered by 
integrating pharmacists into care teams and using patient self-management tools in 25 
communities at community pharmacies, free clinics, worksites, medical clinics, and federally 
qualified health centers. Each community identified a champion responsible for leading the 
implementation that was supported by the APhA Foundation. The evaluation of this program 
demonstrated the value of including pharmacists in care models because of their ability to assist 
in meeting the patients’ needs. Project IMPACT also highlighted the importance of flexibility in 
implementation strategies to allow for customization of patient care.9
Another example is the Pharm2Pharm service model, funded by the Centers for Medicare 
& Medicaid Services Innovation Center. The model aimed to improve care and reduce costs 
by using pharmacists’ expertise to optimize medications during care transitions. The model 
focused on the collaboration between hospital staff, community pharmacists, and primary 
care physicians as patients are being discharged and transition home. In this model, hospital 
pharmacists worked with the hospital care team and case managers to assist with the 
transition to the community, including close communication with community pharmacists 
and physicians. Health information technology supported the program, and all written 
communications between pharmacists and physicians were sent electronically. In the 
Pharm2Pharm model, patients were more likely to achieve hypertension and cholesterol control 
as compared with a control group. The total cost of care for patients receiving Pharm2Pharm 
services decreased by more than 30%, although overall medication costs increased by 20%. 
Medication costs increased due to pharmacists treating previously untreated symptoms and 
addressing effectiveness, safety, and adherence issues.10
Research also demonstrated the effectiveness of a general team-based care model in health-
system settings. The intervention used in one randomized controlled trial with 625 patients 
from 32 varying medical offices in 15 states involved pharmacists communicating with patients, 
making recommendations to physicians about potential changes in medications, and tracking 
the time spent with each patient. At follow-up (9 months later), the average systolic blood 
pressure was 6.1 mmHg lower in the intervention group than in the control group.11
Overcoming Common Barriers to 
Establishing Community-Clinical  
 
 
Linkages Between Community 
Pharmacists and Physicians
Despite the benefits of developing and sustaining community-clinical linkages between 
pharmacists, physicians, and other health care professionals, establishing these linkages is not 
always easy. There are many factors that can affect these linkages. Some of these include the 
traditional culture of health care, understanding the role of pharmacists, and understanding 
pharmacist reimbursement. In spite of these barriers, the accelerating movement toward team-
based care and outcomes-based reimbursement have encouraged and fostered linkages to 
improve the quality, efficiency, and value of our evolving health care system.
Traditional Culture of Health Care
The traditional culture of health care training and practice for pharmacists, physicians, and other 
health care providers has been to work separately. Health care professionals are not accustomed 
to working collaboratively across disciplines or between settings. A study of a large urban 
teaching hospital showed that providers of varying disciplines caring for the same patients 
often could not identify each other and had different priorities for these patients, suggesting 
that coordination of care was “less than optimal.”9 Team-based care has the ability to more 
effectively meet the core expectations of the health care system proposed by the Institute 
of Medicine. These expectations require that care be safe, effective, patient centered, timely, 
efficient, and equitable.12
An example of a successful team-based care model is the Oklahoma Heartland Project 
(Heartland).13 This care-coordination program in Oklahoma targets patients with uncontrolled 
high blood pressure. It connects the local county health department, regional medical 
center, a free community-based health clinic, more than 60 local providers, and pharmacists 
in a protocol-driven strategy to reduce uncontrolled hypertension. Heartland uses public 
health nurses to engage and connect patients identified with uncontrolled hypertension 
to community resources. This model has resulted in 25% of Heartland patients previously 
diagnosed with uncontrolled high blood pressure meeting National Quality Forum 18 within 90 
days of enrollment. Including public health nurses in the model allowed the project to identify 
patient-specific barriers to adherence and have local community-based social services address 
them. Community pharmacists also took on this role of identifying barriers to adherence and 
addressing them through social services.
In addition, interprofessional education has grown significantly over the last decade and is now 
an accreditation standard in pharmacy and other health professions. This approach involves 
collaboration of two or more disciplines in the learning process with the goal of fostering 
interprofessional interactions that enhance the practice of each discipline. Such interdisciplinary 
education is based on mutual understanding and respect for the actual and potential 
contributions of each discipline. The ability to collaborate is vital as the increasing specialization 
and role differentiation of a plethora of health professions combine with the complexity of 
patient care.
Understanding the Role of Pharmacists
Health care has not always been recognized as a team activity. The physician-pharmacist 
relationship traditionally has focused on filling prescription orders rather than on collaborative 
linkages. Collaborations between physicians and pharmacists who are not colocated require 
effective and efficient communication to ensure patients receive timely, high-quality, patient-
centered care. The community-clinical linkage between community pharmacists and physicians 
can begin to change this perception.
Despite numerous success stories from integrated programs, many organizations struggle to 
gain provider engagement and support, which is critical to driving patient use. Establishing 
trust in any relationship is essential. Physicians often do not recognize the benefits of adding 
a pharmacist to the primary care team. Pharmacy support can be viewed as an extension of 
the primary care services and can increase the primary care provider’s capacity to focus on 
non–medication-related issues. Regular meetings with physicians and pharmacists discussing 
success stories, practice-related issues, shared expectations, quality indicators, and patient 
needs may facilitate building trust and promoting effective collaboration.
Understanding Pharmacist Reimbursement
Community-clinical linkages are not dependent on reimbursement to be effective or 
sustainable; in fact, they can be effective without regard to payment. That is, community-
clinical linkages are not dependent on payment and the type of services provided within 
the model and are often within the scope of the health care professionals’ daily activities, just 
more formalized. However, realizing the full value of clinical pharmacy services does depend 
on sustainable payment models. Although resolving the payment and reimbursement issues 
that face clinical pharmacy practice are beyond the scope of this document, pharmacists are 
encouraged to work with partners, payers, health care providers, and peers to explore, discuss, 
and learn about existing and emerging payment models, including value-based approaches 
that support community-clinical linkages. For example, pharmacists may establish community-
clinical linkages with one of the more than 700 accountable care organizations13 as a way 
to seek reimbursement for clinical services. State health departments might also work with 
their Medicaid agency or private payers to create a payment structure for clinical pharmacy 
services or for supporting community health workers who connect patients with health care 
and community resources. In the end, all stakeholders and partners need to be considered to 
maximize resources and create comprehensive and sustainable systems of care for patients with 
chronic diseases.
The LINKAGE Framework
The LINKAGE Framework used in this document describes important strategies when building 
linkages between community pharmacists and physicians, including to:
 
 
 
 
 
 
 
y Learn about the community and clinical sectors.
y Identify and engage key stakeholders from the community and clinical sectors.
y Negotiate and agree upon goals and objectives of the linkage.
y Know which operational structure to implement.
y Aim to coordinate and manage the linkage.
y Grow the linkage with sustainability in mind.
y Evaluate the linkage.
The following sections provide rationale and evidence for why each component of the 
framework is important and specific action steps for community pharmacists and physicians. 
Although in many cases pharmacists are initiating the creation of the linkage, physicians should 
also consider initiating linkage if interested. Examples of successful community-clinical linkages 
between community pharmacists and physicians are included throughout to demonstrate how 
the strategies have been applied in practice.
Learn About the Community and Clinical Sectors
Before implementing a community-clinical linkage between pharmacists and physicians, 
the first step is to identify the unmet health care services needs of the community, including 
existing resources, organizations, health issues, policy, and existing services provided by 
pharmacists and physicians. Comprehensive gathering of information will ensure that the 
community-clinical linkages have a strong purpose, leverage existing community strengths and 
resources, and meet the needs of patients, pharmacists, and physicians.
Action Steps for Pharmacists:
 y Identify pharmacy services that can meet areas of unmet need in the community. 
 y Review the pharmacy practice act within your state and determine whether pharmacists are 
permitted to enter into collaborative practice agreements with physicians. If so:
 y Learn which types of physicians can enter into agreements and in which settings.
 y Learn the types of patient care services pharmacists are allowed to provide.
 y Learn for which health conditions an agreement is allowed.
 y Contact your state and national pharmacy associations to:
 y Identify other pharmacists who have successfully established community linkages or 
practice agreements with physicians to learn how that has been achieved. 
 y Learn about ongoing pharmacist-physician linkage initiatives currently taking place in 
your state.
 y Take the time to learn about physicians’ clinical processes and understand where a pharmacist 
may fit in.
Action Steps for Physicians:
 y Seek examples from your local medical associations on how physicians have created linkages 
with pharmacists and the community to address unmet health service needs. 
 y Seek to understand the scope of services pharmacists can provide for your patients (e.g., 
medication therapy management, medication adherence counseling, lifestyle modification 
counseling, chronic disease management, identification of drug-related problems, smoking 
cessation guidance, and patient self-management education for hypertension, diabetes, and 
other chronic conditions).
Collaborative Action Steps for Pharmacists and Physicians:
 y Host a collaborative meeting between the pharmacist and physician to share information and 
learn about each other’s priorities.
 y Contact your state or local health department or nonprofit health-systems organizations that 
conduct needs assessments to understand the incidence and prevalence of disease within 
your community and identify unmet needs. 
 y Consult with state and local health departments to learn about important ongoing national 
and state health priorities and strategies to improve care, patient outcomes, health care use, 
and health information technology. Consider how a community-clinical linkage between 
community pharmacists and physicians can support these efforts.
 y Take the time to understand how physicians and pharmacists operate in their respective 
practice environments.
Identify and Engage Key Stakeholders  
from Community and Clinical Sectors
Engaging stakeholders is essential to building successful 
community-clinical linkages between pharmacists and 
physicians. Soliciting the opinions, interests, concerns,  
 
 
 
 
 
 
and priorities of key stakeholders from the beginning 
helps address their needs and increase buy-in.1 Building 
trust and relationships is key to gain support for a new 
care model and to develop effective working relationships. 
Often this relationship grows out of the initial conversations 
between a pharmacist and physician about their 
population’s needs and how they can work together to 
better serve their patients and help patients meet their 
therapeutic goals.
Pharmacists in Virginia visited 
potential collaborative 
physicians for face-to-face 
meetings to tell them about 
the pharmacy services 
they could provide to 
patients. These meetings 
strengthened the working 
relationships between the 
pharmacists and physicians 
and led to increased referrals 
for pharmacy services.14
Collaborative Action Steps for Pharmacists 
and Physicians:
y Engage representatives from multiple levels of each organization (e.g., administration/
management, clinical leadership, practitioners) to ensure that activities are integrated and 
supported by all team members.1
y Identify a champion from within each stakeholder group or organization to promote linkage 
activities and align priorities.14
y Share economic and return-on-investment data from previous successful community-clinical 
linkages with decision makers to highlight potential cost/benefit implications (see Table).
Table. Cost Implications from Successful Linkages 
Linkage Project Annual Mean Decrease 
in Costs per Patient
Asheville Project: Diabetes6 $1,200
Asheville Project: Hypertension8 $4,412
Asheville Project: Asthma7 $725
Asheville Project Expansion: Diabetes15 $918
y Use early meetings to:
y Educate stakeholders about pharmacists’ 
training and capabilities using simple, 
understandable terms.
y Discuss the need for integration of pharmacists 
beyond usual care (i.e., the gaps that will be filled 
or addressed).
y Present information showing that the collaboration 
aligns with physicians’ and pharmacists’ missions 
and goals.
y Illustrate how collaboration fits well with physicians’ 
and pharmacists’ workflows and cultures.
y Provide data from past initiatives to demonstrate 
the benefits of team-based care that includes 
pharmacists and physicians.15
y Identify and address stakeholders’ needs 
and concerns.14,16
Stakeholders to Engage1
Participants: Those served or 
affected by the program, such as:
 
 
 
 
 
  
 
 
 
 
 
y Patients or clients
y Caregivers
y Community members
y Community leaders
Implementers: Those involved in 
program operations in community 
and clinical organizations, such as:
y Coordinators
y Liaisons, sometimes referred 
to as spanners
y Frontline practitioners 
(pharmacist, primary 
care physicians)
y Administrators
y Quality improvement staff
y Colleges of pharmacy
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
  
y Colleges of medicine
y State pharmacy associations
y State medical associations
Decision makers: Those who 
can make decisions about the 
community-clinical linkages, such as:
y Local leaders
y National or state leaders
y Senior managers
y Funders
y Purchasers
y Payers
y Employers 
y Local media
Negotiate and Agree on Goals and Objectives of the Linkage 
The mission, goals, and objectives of the linkage should be jointly determined by all 
participating stakeholders and communicated across all levels of the respective organizations. 
It may take time to build the trust needed to negotiate and agree upon a shared mission and 
goals. These goals and objectives should be tailored to the local setting to ensure they are 
relevant and appropriate.1 All collaborating parties should be involved in defining, writing, 
executing, reviewing, and renewing the partnership and associated agreements.16
Collaborative Action Steps for Pharmacists and Physicians:
 
 
 
 
 
 
y Agree on short-term, intermediate, and long-term processes, objectives, and outcome 
measures (including economic, clinical, and humanistic outcomes).1 Objectives should be 
challenging, achievable, and significant. Objectives that are overly ambitious or too cautious 
may discourage stakeholders if they feel they are not achieved or are not worth their time.1
Consider how the linkage between pharmacists and physicians can be used to improve 
health outcomes, communication, flow of information, and lower costs.
y Develop a mission statement and a logic model or diagram to show how linkage activities will 
lead to desired outcomes.1,17
y Specify stakeholder roles and responsibilities and how each will contribute toward reaching 
the objectives (e.g., providing funding, products, services, training, administrative support).
y Align incentives and reimbursement for all team members.14-16
y Appoint a community advisory board to guide and oversee linkage implementation.1
Know Which Operational Structure to Implement
Creating an operational structure will ensure that linkage activities make effective use of 
stakeholder resources to work toward the common goals and objectives. Evaluations of 
community-clinical linkages between pharmacists and physicians have shown that many 
different operational structures can be successful. However, what they have in common is that 
they are built on trusting relationships, leverage the strengths and resources of participating 
stakeholders, and facilitate open communication.
Collaborative Action Steps for Pharmacists and Physicians:
 
 
 
y Determine how the community-clinical linkages between pharmacists and physicians will be 
structured (see Figure). 
 y Define the workflow that will be used by the pharmacist and physician, with specific 
emphasis on how referrals, communication, and documentation will occur.
y Facilitate electronic bidirectional communication between pharmacists and physicians 
through use of electronic health records (EHRs), a health information exchange, or other 
electronic system.16,18 If access to EHRs is not possible for pharmacists, develop a plan for how 
to share necessary patient information efficiently.
y Determine whether a formal agreement will facilitate the linkage. Depending on the nature 
of the partnership, the agreement may be a business agreement such as a contract or 
memorandum of understanding, or it can be a professional agreement that facilitates patient 
care service delivery such as a collaborative practice agreement.1
Figure. The Continuum of Operational Structures for Community-Clinical Linkages 
with  Pharmacists1
Aim to Coordinate and Manage the Linkage
Continued coordination and management is important to ensure that the linkage is running 
smoothly, potential challenges are identified and addressed, and all stakeholders are held 
accountable. Having a coordinator to provide management oversight and administrative 
support for the linkage can help free up physicians and pharmacists to focus on providing 
patient care.19 Coordination and management of a community-clinical linkage can help by:
 
 
 
 
 
 
 
  
  
 
y Engaging and maintaining stakeholders’ interests in the agreed-upon goals and objectives of 
the linkage.
y Providing appropriate infrastructure, resources, and coordination mechanisms to implement 
the chosen strategies.
y Developing ways to promote constructive conflict and manage destructive conflict.
y Implementing information systems to monitor progress over time.
y Adjusting implementation plans when leaders or stakeholders leave their jobs or are no 
longer involved with or committed to the linkage.
y Creating methodology for data collection, as well as a reporting system to track results and 
improve performance.1 Align with performance measures that are deemed important to 
payers and processes that meet expectations of stakeholders within the agreement.
Collaborative Action Steps for Pharmacists and Physicians: 
y Designate one stakeholder organization and staff members with appropriate skills to 
coordinate and facilitate the linkage.1
y Conduct training for participating pharmacists, physicians, and support staff regarding 
the referral-and-feedback process, patient care protocols, documentation, and 
communication protocols.1
y Determine processes for data collection and sharing (see Evaluate the Linkage for 
more information). 
y Provide regular opportunities for pharmacists and physicians to meet, review data, and 
discuss challenges and solutions. In addition to promoting smooth implementation and 
process improvement, these face-to-face meetings will help build trust and relationships.20
Grow the Linkage with Sustainability in Mind
To achieve its stated long-term goals and objectives, it is often 
necessary to grow the community-clinical linkages. Sustainability, 
scalability, and financial viability should all be discussed during 
early planning with stakeholders, particularly payers, employers, 
and other decision makers.14 Starting small, such as working 
with one clinic or provider, allows stakeholders to monitor and 
refine linkage activities before expanding. Focusing on short-
term goals in a small area can lead to small wins, which can build 
momentum, commitment, and trust among stakeholders.1
One persistent challenge in expanding community-clinical 
linkages is the limited number of established mechanisms to 
compensate pharmacists for providing patient care services. 
Therefore, to be successful, those working to integrate 
pharmacists into the health care team need to consider 
sustainability and funding mechanisms from the outset.  
 
 
 
 
 
 
 
 
 
Aligning incentives for patients, physicians, and payers is 
also important to sustain community-clinical linkages with 
community pharmacists.16,21
Collaborative Action Steps for Pharmacists and Physicians:
y Start with a small pilot with one clinic, a small group of 
patients, or a limited linkage protocol. Monitor and revise 
the protocols as necessary. If process and outcome data are 
promising, then scale up to reach more patients, care settings, 
and health conditions.14
y Conduct public education and outreach to inform patients 
about pharmacist and physician collaborative services.14
y Work with payers, employers, and other stakeholders to build 
scalable, sustainable, and financially viable business models.14
y If applicable, provide incentives for patients to participate in 
collaborations, such as eliminating copays for medications and 
medical devices, gift cards, free screenings or consultations, 
and transportation vouchers.14,15,19
y Consider how to provide incentives for pharmacists by working 
with payers and employers to ensure reimbursement and 
compensation for services rendered.21
Work with Employers to 
Sustain Linkages
In the Asheville Project 
and the Diabetes Ten-City 
Challenge, self-insured 
employers provided 
financial support for 
community-clinical linkages 
with pharmacists for eligible 
employees. The employers 
reimbursed pharmacists 
for chronic-disease–related 
patient care services and 
provided incentives for 
participating employees 
(e.g., waived copays for 
medications, transportation 
to appointments). Because 
the employers were at 
risk for their employees’ 
and beneficiaries’ medical 
expenditures, they 
supported the program 
because they believed 
the benefits would 
outweigh the costs. Indeed, 
economic evaluations 
of these programs 
demonstrated a positive 
return on investment in 
terms of lower health care 
use, improved employee 
well-being, and reduced 
absenteeism. These results 
have been used to promote 
expansion of these models 
to new communities 
and employers.6-8,19
Evaluate the Linkage
Evaluating the community-clinical linkage between pharmacists and providers is essential  
 
 
 
 
 
 
to determining how effectively it is achieving its objectives. Different types of evaluation 
include process, outcome, impact, and summative evaluation. The perspectives of different 
stakeholders must be taken into account early in the planning process to determine the goals 
of the evaluation (i.e., what you hope to learn from the evaluation) and data collection and 
access requirements.1
Access to clinical and process data for the evaluation must be discussed early and often 
to ensure data availability and mutual trust among stakeholders. Data sharing agreements 
may be necessary to specify what data may be accessed, and by whom, for the purposes of 
implementing and evaluating the linkage. Data sharing agreements should be developed early 
in the planning process, as they often take time to develop. 
Evaluation Frameworks
The CDC Evaluation Framework in Public Health, which provides general principles for 
program evaluation of public health programs, is one model that can be used to evaluate 
community-clinical linkages.22
The Agency for Healthcare Research and Quality developed the Clinical-Community Relationships 
Measures Atlas that provides a measurement framework that physicians can use in evaluating clinical-
community relationships.23
The Robert Wood Johnson Foundation’s Diabetes Initiative also released a series of checklists that are 
tied to the Framework for Building Clinic-Community Partnerships to Support Chronic Disease 
Control and Prevention. These checklists were designed as tools to assist practitioners in tracking the 
progress and success of their clinical-community relationships.1, 19, 24
Goals of Evaluation:16
 
 
 
 
 
 
 
 
y Track how well the program is being implemented.
y Assess the program’s success.
y Determine what went well, what didn’t, and why.
y Make program improvements using the evaluation results.
y Determine the strength of the partnership.
y Provide support for individual partners to seek funding for their own.
y Document what the partnership has provided for the community as an aid to strengthening 
their support.
y Present or publish in professional, practice, or other settings.
Collaborative Action Steps for Pharmacists and Physicians:
 
 
 
 
y Determine outcomes, measures, and data sources using the goals and objectives outlined at 
the start of collaboration. 
y Identify the availability of data needed to address evaluation questions.
y Begin developing data sharing agreements early.
y Consider how much primary versus secondary data collection is needed for the evaluation.
LINKAGE Summary
 
 
 
 
 
 
 
 
 
 
 
 
y Learn about the community and clinical sectors: Learn about the health care community 
needs that include existing resources, organizations, health issues, policy, and existing services 
provided by pharmacists and physicians. Comprehensive gathering of information will ensure 
that the community-clinical linkages have a strong purpose, leverage existing community 
strengths and resources, and meet the needs of patients, pharmacists, and physicians.
y Identify and engage key stakeholders from the community and clinical sectors: Solicit the 
opinions, interests, concerns, and priorities of key stakeholders from the beginning to help 
address their needs and increase buy-in. Building trust and relationships are key to gaining 
support for a new care model and to develop effective working relationships. 
y Negotiate and agree upon goals and objectives of the linkage: Jointly determine the mission, 
goals, and objectives of the community-clinical linkage and communicate them across all 
levels of the respective organizations. These goals and objectives should be tailored to the 
local setting to ensure they are relevant and appropriate.
y Know which operational structure to implement: The operational structure should be built on 
trusting relationships, leverage the strengths and resources of participating stakeholders, and 
facilitate open communication. 
y Aim to coordinate and manage the linkage: Coordination and management of a community-
clinical linkage deal with the following issues:
y Engaging and maintaining stakeholders’ interests in the agreed-upon goals and 
objectives of the linkage.
y Implementing the chosen strategies by providing appropriate infrastructure, resources, 
and coordination mechanisms.
y Developing ways to promote constructive conflict and manage destructive conflict.
y Implementing information systems to monitor progress over time.
y Adjusting when leaders or stakeholders leave their jobs or are no longer involved with or 
committed to the linkage.
y Grow the linkage with sustainability in mind: Start with a small pilot with just one clinic, a 
small group of patients, or a limited linkage protocol. Monitor and revise the protocols as 
necessary. If process and outcome data are promising, then scale up to reach more patients, 
care settings, and health conditions.
y Evaluate the linkage: Use an evaluation framework to understand how effectively a 
community-clinical linkage is meeting its desired outcomes.
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